Multiple concurrent collagenase clostridium histolyticum injections to Dupuytrens cords: an exploratory study
BMC Musculoskeletal Disorders, 05/04/2012Coleman S et al.
The results provide preliminary evidence that two cords (affected joints) can be treated concurrently with Collagenase clostridium histolyticum (CCH) with similar efficacy and safety as cords treated individually in a sequential fashion. Multiple concurrent injections would eliminate the 30–day wait between single treatments and allow for rapid and effective treatment of patients with multiple affected joints, a significant advantage for both patient and physician.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.